Ikena Oncology Inc.
13F holders, Q2 2024 (June 30)70holders +13
27new positions
15sold out
4famous investors
$1.65avg. 13F price*
At the end of Q2 2024, 70 institutions reported holding Ikena Oncology Inc. in their 13F filings, up 13 from Q1 2024. 27 opened new positions and 15 sold out. The largest holders were Atlas Venture Life Science Advisors, LLC ($8.3M), BVF Inc. ($7.9M) and Blue Owl Capital Holdings LP ($6.8M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ikena Oncology Inc.
- CUSIP
- 45175G108
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $2.9M |
| Exits | 15 | $320K |
All 13F filers, Q1 2024 → Q2 2024: 3,132,351 shares bought and 4,238,018 shares sold, net −1,105,667 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 70 holders
| Atlas Venture Life Science Advisors, LLC | 0.87% | No change | 5,018,178 | $8.3M |
| BVF Inc. | 0.22% | No change | 4,769,164 | $7.9M |
| Blue Owl Capital Holdings LP | 1.88% | Add +5.1% | 4,091,118 | $6.8M |
| Orbimed Advisors LLC | 0.12% | No change | 3,539,358 | $5.8M |
| Omega Fund Management, LLC | 2.75% | No change | 2,249,123 | $3.7M |
| Vanguard Group Inc. | 0.00% | Reduce -10.9% | 1,364,470 | $2.3M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Add +243.1% | 987,900 | $1.6M |
| BML Capital Management, LLC | 0.71% | New | 585,114 | $965K |
| NEA Management Company, LLC | 0.07% | No change | 570,050 | $941K |
| Renaissance Technologies | 0.00% | Reduce -38.7% | 476,400 | $786K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -17.4% | 424,377 | $700K |
| Acuitas Investments, LLC | 0.35% | Add +0.5% | 399,879 | $660K |
| Sofinnova Investments, Inc. | 0.04% | No change | 382,616 | $631K |
| BlackRock Inc. | 0.00% | Reduce -80.6% | 354,842 | $585K |
| Millennium Management | 0.00% | New | 354,710 | $585K |
| Acadian Asset Management LLC | 0.00% | Add +15.2% | 325,713 | $536K |
| Goldman Sachs Group Inc. | 0.00% | Add +277.2% | 273,834 | $452K |
| Geode Capital Management, LLC | 0.00% | Reduce -57.0% | 256,707 | $424K |
| Citadel Advisors | 0.00% | Add +53.9% | 244,690 | $404K |
| Two Sigma Investments, LP | 0.00% | Reduce -2.5% | 236,878 | $391K |
| Northern Trust Corp. | 0.00% | Reduce -7.4% | 216,851 | $358K |
| Barclays PLC | 0.00% | Reduce -0.4% | 196,044 | $323K |
| Two Sigma Advisers, LP | 0.00% | Add +116.8% | 173,200 | $286K |
| Verition Fund Management LLC | 0.00% | Reduce -88.1% | 135,297 | $223K |
| Susquehanna International Group, LLP | 0.00% | New | 83,218 | $137K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 82,300 | $136K |
| Deuterium Capital Management, LLC | 0.22% | New | 80,578 | $133K |
| State Street Corp. | 0.00% | Reduce -83.3% | 80,353 | $133K |
| Centiva Capital, LP | 0.01% | New | 73,431 | $121K |
| Marquette Asset Management, LLC | 0.02% | No change | 72,890 | $120K |
| JBF Capital, Inc. | 0.02% | New | 72,647 | $120K |
| Alpine Global Management, LLC | 0.02% | New | 64,641 | $107K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 60,628 | $100K |
| Jane Street Group, LLC | 0.00% | New | 55,840 | $92K |
| ADAR1 Capital Management, LLC | 0.02% | Add +33.4% | 46,685 | $77K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.02% | New | 45,520 | $75K |
| Marshall Wace, LLP | 0.00% | Reduce -49.3% | 44,933 | $74K |
| UBS Group AG | 0.00% | Add +27.7% | 41,818 | $69K |
| Morgan Stanley | 0.00% | Reduce -17.3% | 40,874 | $67K |
| Dimensional Fund Advisors LP | 0.00% | No change | 38,621 | $64K |
| Qube Research & Technologies Ltd | 0.00% | New | 34,941 | $58K |
| Paloma Partners Management Co | 0.01% | New | 30,240 | $50K |
| Prudential Financial Inc. | 0.00% | Add +76.1% | 29,800 | $49K |
| Virtu Financial LLC | 0.00% | New | 28,053 | $46K |
| Squarepoint Ops LLC | 0.00% | New | 27,666 | $46K |
| HRT Financial LP | 0.00% | New | 26,893 | $44K |
| Corsair Capital Management, L.P. | 0.01% | New | 24,830 | $41K |
| AQR Capital Management | 0.00% | New | 21,861 | $36K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +125.5% | 20,132 | $33K |
| BBR Partners, LLC | 0.00% | New | 20,000 | $33K |
| Berkshire Asset Management LLC | 0.00% | New | 20,000 | $33K |
| FMR LLC | 0.00% | Add +240.8% | 19,767 | $33K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 18,310 | $30K |
| XTX Topco Ltd | 0.00% | Reduce -52.9% | 16,607 | $27K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 16,270 | $27K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -86.0% | 12,066 | $20K |
| Citigroup Inc. | 0.00% | Reduce -13.8% | 5,005 | $8K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 4,842 | $8K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 4,500 | $7K |
| Point72 (DIFC) Ltd | 0.00% | New | 4,392 | $7K |
| Rhumbline Advisers | 0.00% | Reduce -86.1% | 3,856 | $6K |
| Russell Investments Group, Ltd. | 0.00% | New | 2,316 | $4K |
| Macquarie Group Ltd. | 0.00% | New | 1,585 | $3K |
| Cwm, LLC | 0.00% | Add +32733.3% | 985 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -93.6% | 849 | $1K |
| Bank of America Corp. | 0.00% | Reduce -98.3% | 327 | $539 |
| Arax Advisory Partners | 0.00% | New | 299 | $494 |
| New York State Common Retirement Fund | 0.00% | Reduce -98.1% | 283 | $467 |
| Farther Finance Advisors, LLC | 0.00% | Add +385.7% | 170 | $281 |
| Nisa Investment Advisors, LLC | 0.00% | New | 99 | $163 |
"% of holder's portfolio" is IKENA ONCOLOGY INC's weight in each manager's 13F, not the share of Ikena Oncology Inc. the manager owns.